RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation

Cell

Volumn 169, Issue 2, 2017, Pages 301-313.e11

  Daniels, Brian P ^a   Snyder, Annelise G ^a   Olsen, Tayla M ^a   Orozco, Susana ^a   Oguin, Thomas H ^b   Tait, Stephen W G ^c   Martinez, Jennifer ^b   Gale, Michael ^a   Loo, Yueh Ming ^a   Oberst, Andrew ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

chemokines; necroptosis; neuroimmunology; neuroinflammation; RIPK1; RIPK3; West Nile virus

Indexed keywords

CASPASE 8; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 3; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG; CHEMOKINE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK1 PROTEIN, MOUSE; RIPK3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; BRAIN CELL CULTURE; BRAIN HOMOGENATE; CELL DEATH; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS ENCEPHALITIS; VIRUS LOAD; VIRUS REPLICATION; WEST NILE VIRUS; ANIMAL; C57BL MOUSE; CENTRAL NERVOUS SYSTEM; IMMUNOLOGY; LEUKOCYTE; MACROPHAGE; METABOLISM; NECROSIS; NERVE CELL; PHYSIOLOGY; WEST NILE FEVER;

ANIMALS; CENTRAL NERVOUS SYSTEM; CHEMOKINES; LEUKOCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; NECROSIS; NEURONS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 85016457595     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2017.03.011     Document Type: Article

References (67)

1. Bardina, S.V., Michlmayr, D., Hoffman, K.W., Obara, C.J., Sum, J., Charo, I.F., Lu, W., Pletnev, A.G., Lim, J.K., Differential roles of chemokines CCL2 and CCL7 in monocytosis and leukocyte migration during West Nile Virus Infection. J. Immunol. 195 (2015), 4306–4318.
2. Beisner, D.R., Ch'en, I.L., Kolla, R.V., Hoffmann, A., Hedrick, S.M., Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J. Immunol. 175 (2005), 3469–3473.
3. Berger, S.B., Kasparcova, V., Hoffman, S., Swift, B., Dare, L., Schaeffer, M., Capriotti, C., Cook, M., Finger, J., Hughes-Earle, A., et al. Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J. Immunol. 192 (2014), 5476–5480.
4. Berger, S.B., Harris, P., Nagilla, R., Kasparcova, V., Hoffman, S., Swift, B., Dare, L., Schaeffer, M., Capriotti, C., Ouellette, M., et al. Characterization of GSK’963: a structurally distinct, potent and selective inhibitor of RIP1 kinase. Cell Death Dis., 1, 2015, 15009.
5. Brien, J.D., Lazear, H.M., Diamond, M.S., Propagation, quantification, detection, and storage of West Nile virus. Curr. Protoc. Microbiol., 31, 2013 15D.3.1–15D.3.18.
6. Cameron, J.S., Alexopoulou, L., Sloane, J.A., DiBernardo, A.B., Ma, Y., Kosaras, B., Flavell, R., Strittmatter, S.M., Volpe, J., Sidman, R., Vartanian, T., Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J. Neurosci. 27 (2007), 13033–13041.
7. Cho, H., Diamond, M.S., Immune responses to West Nile virus infection in the central nervous system. Viruses 4 (2012), 3812–3830.
8. Cho, Y.S., Challa, S., Moquin, D., Genga, R., Ray, T.D., Guildford, M., Chan, F.K., Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137 (2009), 1112–1123.
9. Daniels, B.P., Klein, R.S., Viral sensing at the blood-brain barrier: new roles for innate immunity at the CNS vasculature. Clin. Pharmacol. Ther. 97 (2015), 372–379.
10. Daniels, B.P., Holman, D.W., Cruz-Orengo, L., Jujjavarapu, H., Durrant, D.M., Klein, R.S., Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. MBio, 5, 2014 e01476–e14.
11. Daniels, B.P., Jujjavarapu, H., Durrant, D.M., Williams, J.L., Green, R.R., White, J.P., Lazear, H.M., Gale, M. Jr., Diamond, M.S., Klein, R.S., Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection. J. Clin. Invest. 127 (2017), 843–856.
12. Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I.L., Korkina, O., Teng, X., Abbott, D., Cuny, G.D., Yuan, C., Wagner, G., et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4 (2008), 313–321.
13. Diamond, M.S., Sitati, E.M., Friend, L.D., Higgs, S., Shrestha, B., Engle, M., A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 198 (2003), 1853–1862.
14. Durrant, D.M., Robinette, M.L., Klein, R.S., IL-1R1 is required for dendritic cell-mediated T cell reactivation within the CNS during West Nile virus encephalitis. J. Exp. Med. 210 (2013), 503–516.
15. Durrant, D.M., Daniels, B.P., Klein, R.S., IL-1R1 signaling regulates CXCL12-mediated T cell localization and fate within the central nervous system during West Nile Virus encephalitis. J. Immunol. 193 (2014), 4095–4106.
16. Durrant, D.M., Williams, J.L., Daniels, B.P., Klein, R.S., Chemokines referee inflammation within the central nervous system during infection and disease. Adv. Med., 2014, 2014, 806741.
17. Durrant, D.M., Daniels, B.P., Pasieka, T., Dorsey, D., Klein, R.S., CCR5 limits cortical viral loads during West Nile virus infection of the central nervous system. J. Neuroinflammation, 12, 2015, 233.
18. Encinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Ceña, V., Gallego, C., Comella, J.X., Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem. 75 (2000), 991–1003.
19. Getts, D.R., Terry, R.L., Getts, M.T., Müller, M., Rana, S., Shrestha, B., Radford, J., Van Rooijen, N., Campbell, I.L., King, N.J., Ly6c+ “inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J. Exp. Med. 205 (2008), 2319–2337.
20. Graham, J.B., Thomas, S., Swarts, J., McMillan, A.A., Ferris, M.T., Suthar, M.S., Treuting, P.M., Ireton, R., Gale, M. Jr., Lund, J.M., Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes. MBio, 6, 2015 e00493–e15.
21. Gutierrez, K.D., Davis, M.A., Daniels, B.P., Olsen, T.M., Ralli-Jain, P., Tait, S.W., Gale, M. Jr., Oberst, A., MLKL activation triggers NLRP3-mediated processing and release of IL-1β independently of Gasdermin-D. J. Immunol. 198 (2017), 2156–2164.
22. He, S., Liang, Y., Shao, F., Wang, X., Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl. Acad. Sci. USA 108 (2011), 20054–20059.
23. Huang, Z., Wu, S.Q., Liang, Y., Zhou, X., Chen, W., Li, L., Wu, J., Zhuang, Q., Chen, C., Li, J., et al. RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice. Cell Host Microbe 17 (2015), 229–242.
24. Ito, Y., Ofengeim, D., Najafov, A., Das, S., Saberi, S., Li, Y., Hitomi, J., Zhu, H., Chen, H., Mayo, L., et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science 353 (2016), 603–608.
25. Kaiser, W.J., Sridharan, H., Huang, C., Mandal, P., Upton, J.W., Gough, P.J., Sehon, C.A., Marquis, R.W., Bertin, J., Mocarski, E.S., Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J. Biol. Chem. 288 (2013), 31268–31279.
26. Keller, B.C., Fredericksen, B.L., Samuel, M.A., Mock, R.E., Mason, P.W., Diamond, M.S., Gale, M. Jr., Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J. Virol. 80 (2006), 9424–9434.
27. Klein, R.S., Lin, E., Zhang, B., Luster, A.D., Tollett, J., Samuel, M.A., Engle, M., Diamond, M.S., Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 79 (2005), 11457–11466.
28. Kok, W.M., New developments in flavivirus drug discovery. Expert Opin. Drug Discov. 11 (2016), 433–445.
29. Kumar, M., Roe, K., Orillo, B., Muruve, D.A., Nerurkar, V.R., Gale, M. Jr., Verma, S., Inflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitis. J. Virol. 87 (2013), 3655–3667.
30. Lawlor, K.E., Khan, N., Mildenhall, A., Gerlic, M., Croker, B.A., D'Cruz, A.A., Hall, C., Kaur Spall, S., Anderton, H., Masters, S.L., et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat. Commun., 6, 2015, 6282.
31. Lim, J.K., Obara, C.J., Rivollier, A., Pletnev, A.G., Kelsall, B.L., Murphy, P.M., Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis. J. Immunol. 186 (2011), 471–478.
32. Liu, T., Zhao, D.X., Cui, H., Chen, L., Bao, Y.H., Wang, Y., Jiang, J.Y., Therapeutic hypothermia attenuates tissue damage and cytokine expression after traumatic brain injury by inhibiting necroptosis in the rat. Sci. Rep., 6, 2016, 24547.
33. Mandal, P., Berger, S.B., Pillay, S., Moriwaki, K., Huang, C., Guo, H., Lich, J.D., Finger, J., Kasparcova, V., Votta, B., et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 56 (2014), 481–495.
34. Michaelis, M., Kleinschmidt, M.C., Doerr, H.W., Cinatl, J. Jr., Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J. Antimicrob. Chemother. 60 (2007), 981–986.
35. Moriwaki, K., Chan, F.K., Necroptosis-independent signaling by the RIP kinases in inflammation. Cell. Mol. Life Sci. 73 (2016), 2325–2334.
36. Moriwaki, K., Bertin, J., Gough, P.J., Chan, F.K., A RIPK3-caspase 8 complex mediates atypical pro-IL-1β processing. J. Immunol. 194 (2015), 1938–1944.
37. Murphy, J.M., Czabotar, P.E., Hildebrand, J.M., Lucet, I.S., Zhang, J.G., Alvarez-Diaz, S., Lewis, R., Lalaoui, N., Metcalf, D., Webb, A.I., et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39 (2013), 443–453.
38. Najjar, M., Saleh, D., Zelic, M., Nogusa, S., Shah, S., Tai, A., Finger, J.N., Polykratis, A., Gough, P.J., Bertin, J., et al. RIPK1 and RIPK3 kinases promote cell-death-independent inflammation by Toll-like receptor 4. Immunity 45 (2016), 46–59.
39. Newton, K., Sun, X., Dixit, V.M., Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell. Biol. 24 (2004), 1464–1469.
40. Newton, K., Dugger, D.L., Maltzman, A., Greve, J.M., Hedehus, M., Martin-McNulty, B., Carano, R.A., Cao, T.C., van Bruggen, N., Bernstein, L., et al. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ. 23 (2016), 1565–1576.
41. Nogusa, S., Thapa, R.J., Dillon, C.P., Liedmann, S., Oguin, T.H. 3rd, Ingram, J.P., Rodriguez, D.A., Kosoff, R., Sharma, S., Sturm, O., et al. RIPK3 activates parallel pathways of MLKL-driven necroptosis and FADD-mediated apoptosis to protect against influenza A virus. Cell Host Microbe 20 (2016), 13–24.
42. Oberst, A., Death in the fast lane: what's next for necroptosis?. FEBS J. 283 (2016), 2616–2625.
43. Ofengeim, D., Ito, Y., Najafov, A., Zhang, Y., Shan, B., DeWitt, J.P., Ye, J., Zhang, X., Chang, A., Vakifahmetoglu-Norberg, H., et al. Activation of necroptosis in multiple sclerosis. Cell Rep. 10 (2015), 1836–1849.
44. Orozco, S., Yatim, N., Werner, M.R., Tran, H., Gunja, S.Y., Tait, S.W., Albert, M.L., Green, D.R., Oberst, A., RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ. 21 (2014), 1511–1521.
45. Pan, Q., Huang, Y., Chen, L., Gu, J., Zhou, X., SMAC-armed vaccinia virus induces both apoptosis and necroptosis and synergizes the efficiency of vinblastine in HCC. Hum. Cell 27 (2014), 162–171.
46. Ramos, H.J., Lanteri, M.C., Blahnik, G., Negash, A., Suthar, M.S., Brassil, M.M., Sodhi, K., Treuting, P.M., Busch, M.P., Norris, P.J., Gale, M. Jr., IL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog., 8, 2012, e1003039.
47. Ransohoff, R.M., Trettel, F., Editorial research topic “Chemokines and chemokine receptors in brain homeostasis”. Front. Cell. Neurosci., 9, 2015, 132.
48. Re, D.B., Le Verche, V., Yu, C., Amoroso, M.W., Politi, K.A., Phani, S., Ikiz, B., Hoffmann, L., Koolen, M., Nagata, T., et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 81 (2014), 1001–1008.
49. Réaux-Le Goazigo, A., Van Steenwinckel, J., Rostène, W., Mélik Parsadaniantz, S., Current status of chemokines in the adult CNS. Prog. Neurobiol. 104 (2013), 67–92.
50. Samuel, M.A., Whitby, K., Keller, B.C., Marri, A., Barchet, W., Williams, B.R., Silverman, R.H., Gale, M. Jr., Diamond, M.S., PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 80 (2006), 7009–7019.
51. Samuel, M.A., Morrey, J.D., Diamond, M.S., Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. J. Virol. 81 (2007), 2614–2623.
52. Sejvar, J.J., Haddad, M.B., Tierney, B.C., Campbell, G.L., Marfin, A.A., Van Gerpen, J.A., Fleischauer, A., Leis, A.A., Stokic, D.S., Petersen, L.R., Neurologic manifestations and outcome of West Nile virus infection. JAMA 290 (2003), 511–515.
53. Suthar, M.S., Diamond, M.S., Gale, M. Jr., West Nile virus infection and immunity. Nat. Rev. Microbiol. 11 (2013), 115–128.
54. Szretter, K.J., Daniels, B.P., Cho, H., Gainey, M.D., Yokoyama, W.M., Gale, M. Jr., Virgin, H.W., Klein, R.S., Sen, G.C., Diamond, M.S., 2′-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog., 8, 2012, e1002698.
55. Takahashi, N., Duprez, L., Grootjans, S., Cauwels, A., Nerinckx, W., DuHadaway, J.B., Goossens, V., Roelandt, R., Van Hauwermeiren, F., Libert, C., et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis., 3, 2012, e437.
56. Teitz, T., Wei, T., Valentine, M.B., Vanin, E.F., Grenet, J., Valentine, V.A., Behm, F.G., Look, A.T., Lahti, J.M., Kidd, V.J., Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med. 6 (2000), 529–535.
57. Upton, J.W., Kaiser, W.J., Mocarski, E.S., Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7 (2010), 302–313.
58. Upton, J.W., Kaiser, W.J., Mocarski, E.S., DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11 (2012), 290–297.
59. Vasek, M.J., Garber, C., Dorsey, D., Durrant, D.M., Bollman, B., Soung, A., Yu, J., Perez-Torres, C., Frouin, A., Wilton, D.K., et al. A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature 534 (2016), 538–543.
60. Vitner, E.B., Salomon, R., Farfel-Becker, T., Meshcheriakova, A., Ali, M., Klein, A.D., Platt, F.M., Cox, T.M., Futerman, A.H., RIPK3 as a potential therapeutic target for Gaucher's disease. Nat. Med. 20 (2014), 204–208.
61. Wang, Y., Lobigs, M., Lee, E., Müllbacher, A., CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J. Virol. 77 (2003), 13323–13334.
62. Wang, H., Sun, L., Su, L., Rizo, J., Liu, L., Wang, L.F., Wang, F.S., Wang, X., Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell 54 (2014), 133–146.
63. Wang, X., Jiang, W., Yan, Y., Gong, T., Han, J., Tian, Z., Zhou, R., RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat. Immunol. 15 (2014), 1126–1133.
64. Williams, J.L., Holman, D.W., Klein, R.S., Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers. Front. Cell. Neurosci., 8, 2014, 154.
65. Williams, J.L., Patel, J.R., Daniels, B.P., Klein, R.S., Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system. J. Exp. Med. 211 (2014), 791–799.
66. Xu, Y., Wang, J., Song, X., Qu, L., Wei, R., He, F., Wang, K., Luo, B., RIP3 induces ischemic neuronal DNA degradation and programmed necrosis in rat via AIF. Sci. Rep., 6, 2016, 29362.
67. + T cells. Science 350 (2015), 328–334.